| http://www.w3.org/ns/prov#value | - We are proud of the significant milestones that we haveachieved so far this year including our transition to a Phase III stage companywith Pimavanserin, the announcement of positive results from our large Phase IIschizophrenia co-therapy trial, the investigation of our Phase IIb trial withACP-104 and the strengthening of our balance sheet.
|
